Aspen Aerogels (NYSE:ASPN) Given “Buy” Rating at Roth Mkm

Roth Mkm restated their buy rating on shares of Aspen Aerogels (NYSE:ASPN) in a research report sent to investors on Tuesday, Benzinga reports. The firm currently has a $22.00 price target on the construction company’s stock.

Other analysts have also issued reports about the stock. TheStreet upgraded shares of Aspen Aerogels from a d+ rating to a c- rating in a report on Wednesday, March 6th. HC Wainwright restated a buy rating and issued a $20.00 price objective on shares of Aspen Aerogels in a report on Wednesday, February 14th. One analyst has rated the stock with a sell rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of Moderate Buy and an average price target of $19.00.

Aspen Aerogels Stock Performance

Aspen Aerogels stock opened at $15.65 on Tuesday. The company has a current ratio of 3.41, a quick ratio of 2.91 and a debt-to-equity ratio of 0.24. The firm has a 50-day moving average of $16.45 and a 200-day moving average of $13.49. The firm has a market cap of $1.20 billion, a P/E ratio of -23.71 and a beta of 2.04. Aspen Aerogels has a 1-year low of $5.32 and a 1-year high of $19.10.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings data on Tuesday, February 13th. The construction company reported ($0.01) EPS for the quarter, topping the consensus estimate of ($0.12) by $0.11. Aspen Aerogels had a negative net margin of 19.19% and a negative return on equity of 10.47%. The business had revenue of $84.22 million during the quarter, compared to analyst estimates of $83.82 million. During the same period last year, the business posted ($0.20) earnings per share. Sell-side analysts expect that Aspen Aerogels will post -0.24 EPS for the current year.

Hedge Funds Weigh In On Aspen Aerogels

Large investors have recently made changes to their positions in the business. Banque Cantonale Vaudoise lifted its holdings in shares of Aspen Aerogels by 37.5% during the first quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock valued at $81,000 after purchasing an additional 1,252 shares during the last quarter. McAdam LLC bought a new stake in shares of Aspen Aerogels during the fourth quarter valued at approximately $191,000. Mirae Asset Global Investments Co. Ltd. increased its position in shares of Aspen Aerogels by 71.4% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 23,052 shares of the construction company’s stock valued at $198,000 after acquiring an additional 9,601 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Aspen Aerogels by 38.5% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company’s stock valued at $205,000 after acquiring an additional 3,607 shares in the last quarter. Finally, Cornerstone Investment Partners LLC bought a new stake in shares of Aspen Aerogels during the fourth quarter valued at approximately $230,000. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.